Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

U.S. patent issues to Vivus for second-generation ED therapeutic

March 29, 1999

Asahi Chemical launches alpha-adrenoceptor antagonist in Japan

March 26, 1999

Potassium and/or chloride channel modulators claimed for incontinence and IBS

March 25, 1999

Dainippon's AH-9700 is an excellent candidate for treatment of urge incontinence

March 25, 1999

Recordati presents new series for lower urinary tract dysfunction

March 24, 1999

American Home Products patents selective, orally active, nonpeptide V2 agonists

March 24, 1999

Piperazine derivatives for lower urinary tract disorders designed at Recordati

March 23, 1999

Ono-4057: BLT receptor antagonist with beneficial effects in rat model of nephritis

March 22, 1999

TGF-beta inhibitors for nephritis disclosed by Tsumura

March 16, 1999

Zeria patents new series for BPH

March 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...